• Acta clinica Croatica · Jun 2020

    Localization and shape of stenoses in central lung carcinoma - Sensitivity and precision of MDCT VB and FB.

    • Mitko Atanasov Mitev, Evelin Dosev Obretenov, and Daniel Georgiev Valchev.
    • 1Department of Medical Physics, Biophysics, Roentgenology and Radiology, Faculty of Medicine, Department of Diagnostic Imaging, St. Kirkovich University Hospital, Trakia University-Stara Zagora, Stara Zago... more ra, Bulgaria; 2Department of Special Surgery/Thoracic Surgery, Vascular Surgery, Pediatric Surgery and Orthopedics and Traumatology, Faculty of Medicine, Division of Thoracic Surgery, St. Kirkovich University Hospital, Trakia University-Stara Zagora, Stara Zagora, Bulgaria. less
    • Acta Clin Croat. 2020 Jun 1; 59 (2): 252-259.

    AbstractThe objective is to present diagnostic capabilities of virtual bronchoscopy (VB) and fiberoptic bronchoscopy (FB) for determining the localization and shape of stenoses in patients with central lung carcinoma. A systematic study was performed on 220 patients aged 11-83 (54.36±17.24) years with endobronchial disease using the FB and VB methods during the 2013-2017 period. Central carcinoma of the lung was found on VB in 130 patients and on FB in 120 patients. Other nosologic diseases were found in 22 patients. Right localization of central carcinoma prevailed over left localization in both sexes. A significant difference in the localization criterion was found in female patients examined by VB (U-test, p=0.01). VB and FB yielded 86.5% vs. 91.60% precision and 85% vs. 94.5% sensitivity. In conclusion, VB was found to be a successful noninvasive method for determining the localization of lung tumors and shape of stenoses, which are essential in the diagnosis of malignant processes.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.